The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Open accessAbstract
Polymer-based microparticles are in clinical use mainly for their ability to provide controlled release of peptides and compounds, but they are also being explored for their potential to deliver vaccines and drugs as suspensions directly into mucosal sites. It is generally assumed that uptake is mediated by epithelial M cells, but this is often not directly measured. To study the potential for optimizing M cell uptake of polymer microparticles in vivo, we produced sub-micron size PLGA particles incorporating a recombinant protein. This recombinant protein was produced with or without a c-terminal peptide previously shown to have high affinity binding to Claudin 4, a protein associated with M cell endocytosis. While the PLGA nanoparticles incorporate the protein throughout the matrix, much of the protein was also displayed on the surface, allowing us to take advantage of the binding activity of the targeting peptide. Accordingly, we found that instillation of these nanoparticles into the nasal passages or stomach of mice was found to significantly enhance their uptake by upper airway and intestinal M cells. Our results suggest that a reasonably simple nanoparticle manufacture method can provide insight into developing an effective needle-free delivery system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CPE30, the C-terminal 30 amino acid part of CPE, was coated to PLGA NPs, which increased the uptake by upper airways when administered intranasally or by intestinal M cells after ingestion [101].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [101]
In the citing paper
“The latter functions as a receptor for Clostridium perfringens enterotoxin (CPE) and has been recent focus for targeting approaches [101].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clostridium perfringens Enterotoxin Fragment Removes Specific Claudins from Tight Junction Strands
Sonoda, N., Furuse, M., Sasaki, H., Yonemura, S., Katahira, J., Horiguchi, Y., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.195 · Cited by 612
Rahner, C., Mitic, L. L., & Anderson, J. M. (2001) · Gastroenterology · doi:10.1053/gast.2001.21736 · Cited by 546
Jiang, W., Rk, G., DESHPANDE, M., & Schwendeman, S. P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 480
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., & Gilley, R. M. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.2978-2986.1991 · Cited by 365
Katahira, J., Inoue, N., Horiguchi, Y., Matsuda, M., & Sugimoto, N. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.6.1239 · Cited by 278
Katahira, J., Sugiyama, H., Inoue, N., Horiguchi, Y., Matsuda, M., & Sugimoto, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26652 · Cited by 273
Sansonetti, P. J., & Phalipon, A. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0175 · Cited by 269
How to achieve sustained and complete protein release from PLGA-based microparticles?
Giteau, A., Venier‐Julienne, M., Aubert‐Pouëssel, A., & Benoît, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.012 · Cited by 268
Crotts, G., & Park, T. G. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809008253 · Cited by 263
Blanco, D., & Alonso, M. J. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00011-3 · Cited by 252
Flagged first, then by citations
1 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–137 of 137
Schreiner, J., Brettner, F. E. B., Gier, S., Vogel‐Kindgen, S., & Windbergs, M. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114408 · Cited by 8
Microbiome in Colonic Carcinogenesis
Sun, J., & Xia, Y. (2023) · Comprehensive physiology · doi:10.1002/cphy.c210052 · Cited by 10
Feng, P., Seo, J., Li, J., Jung, H. Y., & Jung, Y. J. (2025) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2025.117633 · Cited by 6
Jepson, M. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386940-1.00012-x · Cited by 6
Deb, S., Zhang, Y., An, Y., Xia, Y., & Sun, J. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101682 · Cited by 5
NANOSTRUCTURES OVERCOMING THE INTESTINAL BARRIER: DRUG DELIVERY STRATEGIES
Ryan, K. B., Maher, S., Brayden, D. J., & O’Driscoll, C. M. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735292-00063 · Cited by 5
Stable Recombinant Invasion Plasmid Antigen C (IpaC)-Based Single Dose Nanovaccine for Shigellosis
Baruah, N., Halder, P., Koley, H., & Katti, D. S. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00378 · Cited by 5
Shah, D., & Londhe, V. Y. (2011) · Therapeutic Delivery · doi:10.4155/tde.10.102 · Cited by 5
Calderon-Nieva, D. (2018) · UWSpace (University of Waterloo) · Cited by 5
Elsutohy, M. M., Abdelaziz, D. H., Dalton, C. S., Kruger, B., Phan, S., Cheng, Y.-C., Low, K., Ahmed-Hassan, H., & Schätzl, H. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-31381-8 · Cited by 4
Polymers Used in Peyer’s Patch Targeting
Patel, D. H., Talele, D. R., Pathak, D., & Misra, A. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819659-5.00006-9 · Cited by 4
Engineered MCM-48 nanoparticles as potential carriers for oral vaccine delivery
Min, C. H., Kim, S., Park, C. G., Kim, S., Kim, C. R., Ji, H. B., Han, J. H., Kim, M. J., Choi, G., & Choy, Y. B. (2023) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2023.08.033 · Cited by 4
Ogasawara, N., Yamamoto, K., Takano, K., & Himi, T. (2016) · Advances in oto-rhino-laryngology · doi:10.1159/000441868 · Cited by 4
Applications of Polymers in Delivery of Biologics
Inamdar, N., & Mourya, V. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819659-5.00016-1 · Cited by 4
Role of targeting nanoparticles for cancer immunotherapy and imaging
Wen, R. M., & Umeano, A. C. (2017) · Trends in Immunotherapy · doi:10.24294/ti.v1.i3.95 · Cited by 3
Sun, L., Zhao, N., Li, H., Wang, B., Li, H., Zhang, X., & Zhao, X. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.12.014 · Cited by 3
PLGA-based nanoparticles for treatment of infectious diseases
Buescher, J., Novak, A. W., Khan, S. A., Weiss, A., Lee, S., & Schneider, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91215-0.00014-5 · Cited by 3
Chiang, J.-Y., Lin, T.-H., Cheng, J.-X., & Pan, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141336 · Cited by 3
Epithelial Permeation and Absorption Mechanisms of Biopharmaceuticals
Nielsen, H. M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9524-6_4 · Cited by 3
Mucosal vaccine delivery: is M cell-targeted delivery effective in the mucosal lumen?
Lo, D. D. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.740008 · Cited by 3
Self-citationIdentification of Adhesin–Receptor Interactions Driving Bacterial Translocation through M Cells
Martínez‐Argudo, I., & Jepson, M. A. (2010) · Future Microbiology · doi:10.2217/fmb.10.23 · Cited by 3
Quang, H. K., Nguyen, A. H., Pham, Q. T. M., Nguyen, H. P. K., & Tran, H. V. (2019) · Science and Technology Development Journal - Natural Sciences · doi:10.32508/stdjns.v2i4.809 · Cited by 2
Wen, Y., Sparks, Z., Hawkins, I. K., Lednicky, J. A., Abboud, G., Nelson, C. D., Chauhan, A., & Driver, J. P. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114365 · Cited by 2
Role of targeting nanoparticles for cancer immunotherapy and imaging
Wen, R. M., & Umeano, A. C. (2019) · Trends in Immunotherapy · doi:10.24294/ti.v3.i2.95 · Cited by 1
Functionalized nanoparticles for targeting the gastrointestinal apical membrane receptors
Araújo, F., Pereira, C. S. M., Santos, H. A., Granja, P. L., & Sarmento, B. F. C. C. (2016) · doi:10.4155/fseb2013.13.63 · Cited by 1
The Design of Novel Nano-Sized Polyanion-Polycation Complexes for Oral Protein Delivery
Khan, A. A. (2014) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.13773
Aliphatic Polyesters: Particulate Vaccine Delivery
Silva, J. M., Véronique Préat, A., & Florindo, H. F. (2016) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120050384
Quang, H. K., Gia, M. Q., An, N. H., Ha, V. T. T., & Hiếu, T. V. (2019) · Science and Technology Development Journal - Natural Sciences · doi:10.32508/stdjns.v3i1.723
Nanocarriers for delivery of biotherapeutics to intestinal mucosa
Zhu, X. D., & Huang, Y. (2015) · doi:10.4155/fseb2013.14.36
M cell: intestinal immunity’s gateway
Tran‐Van, H., Le-Dao, H.-A., & Dinh, T. M. (2021) · Science and Technology Development Journal - Natural Sciences · doi:10.32508/stdjns.v5i4.1111
Sustained release of inactivated H1N1 virus from degradable microparticles for extended vaccination
Sparks, Z., Wen, Y., Hawkins, I. K., Lednicky, J. A., Abboud, G., Nelson, C. D., Driver, J. P., & Chauhan, A. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114388
Zhang, F., Ni, L., Zhang, Z., Luo, X., Wang, X., Zhou, W., Chen, J., Liu, J., Qu, Y., Liu, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25284826
Baruah, N., Ahamad, N., Halder, P., Koley, H., & Katti, D. S. (2024) · Figshare · doi:10.6084/m9.figshare.26564841
Vaccination à ADN intranasale sur un modèle porcin
Souci, L. (2020) · theses.fr (ABES) · doi:10.70675/a63b0317z2970z4d8dzbfecz33daef66d935
Fu, Y., Cao, C., Jiao, Y., Cao, Y., Hao, H., Cui, X., Gao, D., Gao, Y., Zhang, Q., & Liu, Y. (2026) · Nanoscale · doi:10.1039/d6nr02259f
SurR9-C84A mutant nanocarrier and milk protein therapeutics for neurological disorders
Sriramoju, B. (2014) · Own your potential (DEAKIN)
Metadata
- Authors
- Rajapaksa, T. E., Stover-Hamer, M., Fernandez, X., Eckelhoefer, H. A., & Lo, D. D.
- Affiliations
- University of California, Riverside (US)
- Corresponding author
- Lo, David D.
- ORCID
- Lo, David D.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 142
- Issue
- 2
- Pages
- 196-205
- ISSN
- 0168-3659 (ISSN-L)
- PMC
- PMC2823968
- OpenAlex
- W1973426656
- Cited by
- 137
- References
- 50
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 11 · 2022: 6 · 2021: 5 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 10 · 2016: 8 · 2015: 8 · 2014: 12 · 2013: 11 · 2012: 14
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Foundation for the National Institutes of Health
- Harvard University
- National Institute of Allergy and Infectious Diseases (AI73689, R01AI063426, R43AI058434, R21AI073689)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- claudin-4, M cells, PLGA nanoparticles, targeted drug delivery, mucosal drug delivery, nasal instillation, upper airway, vaccine delivery
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Biological Transport, Cell Line, Cricetulus, Drug Carriers, Cricetinae, Hemagglutinins, Membrane Proteins, Mucous Membrane, Influenza A virus, Peyer's Patches, Polyglycolic Acid, Recombinant Proteins, CHO Cells, Lactic Acid, Mice, Nanoparticles, Claudin-4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
